Novo Nordisk A/S, Eli Lilly and Company, And Novartis AG Said to Bid for Ascendis Pharma A/S; Offer is Rumored to be About $400 Million

Bloomberg -- Novo Nordisk A/S, Novartis AG’S Sandoz and Eli Lilly & Co. are among bidders for Ascendis Pharma A/S of Denmark, a person with knowledge of the matter said.